StreetInsider.com News Articles

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

The analyst comments "This morning an X post from a Fox News source says the Florida State Directed Payment Program has been approved, with $7.8b Medicaid funds to be released. The official preprint has not yet been posted. We have not received independent verification from our hospital coverage, although GA and other programs have recently been approved. We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC."

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'

Thu, 12 Mar 2026 13:13:20 -0400

TD Cowen: 'We est ~+3%/+2%/ +2%/+1% EBITDA pickup for HCA/UHS/THC/ACHC'.

Form SCHEDULE 13G Acadia Healthcare Compan Filed by: Khrom Investments Fund, LP

Wed, 11 Mar 2026 21:45:00 -0400

si-local-file:///var/storage/secattach/20260311/26147881.html

Form SCHEDULE 13G Acadia Healthcare Compan Filed by: Khrom Investments Fund, LP

Wed, 11 Mar 2026 21:45:00 -0400

si-local-file:///var/storage/secattach/20260311/26147881.html

Acadia Healthcare (ACHC) PT Raised to $20 at Barclays

Tue, 03 Mar 2026 05:57:06 -0400

Barclays analyst Andrew Mok raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $20.00 (from $14.00) while maintaining a Equalweight rating.

Acadia Healthcare (ACHC) PT Raised at RBC Capital; 'Shares jump as new CEO shores up investor confidence'

Mon, 02 Mar 2026 09:08:40 -0400

RBC Capital analyst Ben Hendrix raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $28.00 (from $17.00) while maintaining an Outperform rating.

The analyst commented: "Shares jump as new CEO shores up investor confidence; We were pleased to see ACHC shares jump over 21% following 4Q results and initial 2026 guidance. We are encouraged by Ms. Osteen's increased focus on operating detail and capital discipline, which we believe also resonated with investors. We are maintaining our Outperform rating and increasing our price target to $28 (previously $17) as we roll our valuation to 2027."

Acadia Healthcare (ACHC) PT Raised at RBC Capital; 'Shares jump as new CEO shores up investor confidence'

Mon, 02 Mar 2026 09:08:40 -0400

RBC Capital analyst Ben Hendrix raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $28.00 (from $17.00) while maintaining an Outperform rating.

Form 4 Acadia Healthcare Compan For: Feb 27 Filed by: Farley Brian

Fri, 27 Feb 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260227/26083283.html

Form 4 Acadia Healthcare Compan For: Feb 27 Filed by: Farley Brian

Fri, 27 Feb 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260227/26083283.html

Form 10-K Acadia Healthcare Compan For: Dec 31

Fri, 27 Feb 2026 06:07:00 -0400

http://archive.fast-edgar.com/20260227/AA2V522CZZ2RC2ZZ2HZD2MYPS5OUZZ22Z286

Filed on: February 27, 2026

Form 10-K Acadia Healthcare Compan For: Dec 31

Fri, 27 Feb 2026 06:07:00 -0400

http://archive.fast-edgar.com/20260227/AA2V522CZZ2RC2ZZ2HZD2MYPS5OUZZ22Z286

Filed on: February 27, 2026

Raymond James on Acadia Healthcare (ACHC): '2026 Guide Not as Bad as Feared – Management Change a New Hope'

Thu, 26 Feb 2026 10:52:44 -0400

Raymond James analyst John Ransom reiterated an Outperform rating and $25.00 price target on Acadia Healthcare (NASDAQ: ACHC).

The analyst comments "We reiterate our Outperform rating while maintaining our $25 price target on ACHC following 4Q25 results that were inline with previously lowered guidance as the company reported adj. EBITDA of $99.8M (Street: $95.4M; RJe: $95.9M). The 2026 EBITDA guidance of $575-610M (Street: $612.7M, RJ: $591.0M) was roughly in line with commentary management gave at a recent conference, but better than some buyside expectations. Capex is anticipated to decline ~$300M y/y and FCF embedded in guidance is expected to be ~$33M

Acadia Healthcare (ACHC) PT Raised to $24 at TD Cowen

Thu, 26 Feb 2026 10:21:55 -0400

TD Cowen analyst Ryan Langston raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $24.00 (from $22.00) while maintaining a rating.

Acadia Healthcare (ACHC) PT Raised to $20 at Cantor Fitzgerald

Thu, 26 Feb 2026 09:24:48 -0400

Cantor Fitzgerald analyst Sarah James raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $20.00 (from $17.00) while maintaining a Neutral rating.

Acadia Healthcare (ACHC) PT Raised to $27 at UBS

Thu, 26 Feb 2026 09:11:31 -0400

UBS analyst AJ Rice raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $27.00 (from $24.00) while maintaining a Buy rating.

Acadia Healthcare (ACHC) PT Raised to $28 at RBC Capital

Thu, 26 Feb 2026 07:30:46 -0400

RBC Capital analyst Ben Hendrix raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $28.00 (from $17.00) while maintaining an Outperform rating.

Acadia Healthcare (ACHC) PT Raised to $28 at RBC Capital

Thu, 26 Feb 2026 07:30:46 -0400

RBC Capital analyst Ben Hendrix raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $28.00 (from $17.00) while maintaining an Outperform rating.

Acadia Healthcare (ACHC) PT Raised to $20 at Mizuho

Thu, 26 Feb 2026 06:41:17 -0400

Mizuho analyst Ann Hynes raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $20.00 (from $17.00) while maintaining a Neutral rating.

Acadia Healthcare (ACHC) PT Raised to $22 at Leerink Partners

Thu, 26 Feb 2026 06:21:48 -0400

Leerink Partners analyst Whit Mayo raised the price target on Acadia Healthcare (NASDAQ: ACHC) to $22.00 (from $14.00) while maintaining a Market Perform rating.

The analyst comments "Bottom Line: Reiterate Market Perform rating. The opportunity here is quite apparent. ACHC has arguably been mismanaged for some time, has drifted as an organization, and has over spent for years. Margins are now meaningfully lower over a multi-year timeframe. The company is taking a deep introspective review of the organization and capital priorities. The result is finding a lot of embedded earnings, changes in processes and accountability, and perhaps a flattened organization. The